Completed NA INTERVENTIONAL 2-arm NCT02157155

A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis

The Role of ATGL and G0/G1 Switch Gene Complex in Lipopolysaccaride (LPS) Induced Ketosis - a Controlled, Randomised, Clinical Experimental Study

Sponsor: University of Aarhus

Conditions Diabetes Mellitus Type 1 Ketoacidosis

Interventions LPS

Updated 5 times since 2017 Last updated: Dec 1, 2015 Started: Jun 30, 2014 Primary completion: Mar 31, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02157155, this NA trial focuses on Diabetes Mellitus Type 1 and Ketoacidosis and remains completed. Sponsored by University of Aarhus, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Aarhus

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus, Denmark